Schedule these 10 health tests when you turn 65

January 29, 2020 Providence Seniors Health Team

Health care during your senior years is considerably more complicated than the screenings and services you needed in your youth. You may have multiple health issues that require juggling numerous specialists, tests and medications to manage your care. Doctor’s visits may become more frequent than your yearly physical, or a couple visits to treat a cold or minor injury. You may need to be more vigilant about maintaining your health and require more testing, more often to stay ahead of your health challenges.

Your doctor can help you determine which screenings and tests you need to protect your health and identify any problems before they advance into serious health issues.

Here are 10 tests to schedule if you’re age 65 or older.

Find a doctor

Regardless of your age, it’s always better to identify potential health issues before they become permanent problems. The geriatric specialists at Providence can help you follow a testing timeline for preventive screenings that meets your needs. You can find a Providence geriatric specialist using our provider directory. Or you can search for a primary care doctor in your area.

Related Resources

Malnutrition in older adults

Low-impact exercises to stay fit as you age

Why older adults should review their medications

This information is not intended as a substitute for professional medical care. Always follow your healthcare professional's instructions.

About the Author

From how to identify and treat heart diseases to exercise tips to maintain an active lifestyle, the Providence Senior's Health team is committed to providing real-world advice that is hyper-relevant to helping those 65+ find ways stay young at heart
More Content by Providence Seniors Health Team

Welcome to your journey for creating a healthier you

Schedule these 10 health tests when you turn 65

About the Author

Previous Article

Next Article

Schedule these 10 health tests when you turn 65

About the Author

Previous Article

Next Article

Other content in this Stream

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

Cancer survivor Mark Williams chats with Dr. Brendan Curti about

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.